These final results, along with a earlier report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 support the principle of targeting ACKR3 as a singular approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-linked disorders. Morphine and various opioids https://maynards013iww0.blogdiloz.com/profile